These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22704727)

  • 1. Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study.
    Wagenlehner FM; van Oostrum E; Tenke P; Tandogdu Z; Çek M; Grabe M; Wullt B; Pickard R; Naber KG; Pilatz A; Weidner W; Bjerklund-Johansen TE;
    Eur Urol; 2013 Mar; 63(3):521-7. PubMed ID: 22704727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluoroquinolone-resistant Escherichia coli among the rectal flora is the predominant risk factor for severe infection after transrectal ultrasound-guided prostate biopsy: a prospective observational study.
    Holmbom M; Forsberg J; Fredrikson M; Nilsson M; Nilsson LE; Hanberger H; Hällgren A
    Scand J Urol; 2023 Aug; 58():32-37. PubMed ID: 37553957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The negative aftermath of prostate biopsy: prophylaxis, complications and antimicrobial stewardship: results of the global prevalence study of infections in urology 2010-2019.
    Alidjanov JF; Cai T; Bartoletti R; Bonkat G; Bruyère F; Köves B; Kulchavenya E; Medina-Polo J; Naber K; Perepanova T; Pilatz A; Tandogdu Z; Bjerklund Johansen TE; Wagenlehner FM
    World J Urol; 2021 Sep; 39(9):3423-3432. PubMed ID: 33615393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic susceptibility of intestinal Escherichia coli in men undergoing transrectal prostate biopsies: a prospective, registered, multicentre study.
    Knaapila J; Kallio H; Hakanen AJ; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Gunell M; Boström PJ
    BJU Int; 2018 Aug; 122(2):203-210. PubMed ID: 29533507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
    Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
    Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of fluoroquinolone-resistant rectal flora in patients undergoing transrectal ultrasound-guided prostate needle biopsy: A prospective multicenter study.
    Chung HS; Hwang EC; Yu HS; Jung SI; Lee SJ; Lim DH; Cho WJ; Choe HS; Lee SJ; Park SW
    Int J Urol; 2018 Mar; 25(3):278-283. PubMed ID: 29241300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
    BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of fluoroquinolone resistant infections after prostate biopsy--are fluoroquinolones still effective prophylaxis?
    Feliciano J; Teper E; Ferrandino M; Macchia RJ; Blank W; Grunberger I; Colon I
    J Urol; 2008 Mar; 179(3):952-5; discussion 955. PubMed ID: 18207185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Complications Leading to a Health Care Contact After Transrectal Prostate Biopsies: A Prospective, Controlled, Multicenter Study Based on a Selected Study Cohort.
    Knaapila J; Gunell M; Syvänen K; Ettala O; Kähkönen E; Lamminen T; Seppänen M; Jambor I; Rannikko A; Riikonen J; Munukka E; Eerola E; Hakanen AJ; Boström PJ
    Eur Urol Focus; 2019 May; 5(3):443-448. PubMed ID: 29275146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Febrile urinary tract infection after prostate biopsy and quinolone resistance.
    Choi JW; Kim TH; Chang IH; Kim KD; Moon YT; Myung SC; Kim JW; Kim MS; Kwon JK
    Korean J Urol; 2014 Oct; 55(10):660-4. PubMed ID: 25324949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone-based antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided prostate biopsy.
    Sieczkowski M; Gibas A; Bronk M; Matuszewski M
    Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1815-21. PubMed ID: 26048634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosfomycin for Antibiotic Prophylaxis in Men Undergoing a Transrectal Prostate Biopsy: A Systematic Review and Meta-Analysis.
    Gu HM; Gu JS; Chung HS; Jung SI; Kwon D; Kim MH; Jung JH; Han MA; Kang SJ; Hwang EC; Dahm P
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241143
    [No Abstract]   [Full Text] [Related]  

  • 14. A prospective randomized comparative study of targeted versus empirical prophylactic antibiotics in the prevention of infective complications following transrectal ultrasound-guided prostate biopsy.
    Doherty AF; Ikuerowo SO; Jeje EA; Ibrahim NA; Ojongbede OL; Mutiu WB; Omisanjo OA; Abolarinwa AA
    Ann Afr Med; 2019; 18(3):132-137. PubMed ID: 31417013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.
    Liss MA; Taylor SA; Batura D; Steensels D; Chayakulkeeree M; Soenens C; Rao GG; Dash A; Park S; Patel N; Woo J; McDonald M; Nseyo U; Banapour P; Unterberg S; Ahlering TE; Van Poppel H; Sakamoto K; Fierer J; Black PC
    J Urol; 2014 Dec; 192(6):1673-8. PubMed ID: 24928266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.
    Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y
    Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
    Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
    Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute bacterial prostatitis after transrectal ultrasound-guided prostate biopsy: epidemiological, bacteria and treatment patterns from a 4-year prospective study.
    Campeggi A; Ouzaid I; Xylinas E; Lesprit P; Hoznek A; Vordos D; Abbou CC; Salomon L; de la Taille A
    Int J Urol; 2014 Feb; 21(2):152-5. PubMed ID: 23906113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and significance of fluoroquinolone-resistant bacteria carriage in patients undergoing transrectal ultrasound prostate biopsy.
    Hasanzadeh A; Pourmand MR; Alizadeh A; Pourmand G
    Urol J; 2017 May; 14(3):3085-3090. PubMed ID: 28537050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU).
    Choe HS; Lee SJ; Cho YH; Çek M; Tandoğdu Z; Wagenlehner F; Bjerklund-Johansen TE; Naber K;
    J Infect Chemother; 2018 Apr; 24(4):278-283. PubMed ID: 29292177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.